Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Clinical Study to Evaluate Safety and Tolerability of Magnetic Human Corneal Endothelial Cells in the Treatment of Corneal Edema

NCT04191629 is registered in ClinicalTrials.gov with Valeria Sanchez-Huerta as lead sponsor.

NCT NCT04191629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04191629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Clinical Study to Evaluate Safety and Tolerability of Magnetic Human Corneal Endothelial Cells in the Treatment of Corneal Edema
Lead sponsor
Valeria Sanchez-Huerta
Phase
Phase 1
Overall status
Unknown status
Start date
May 4, 2016
Completion date
February 28, 2021
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal edema, corneal endothelial dystrophy, corneal transplant failure, fuchs dystrophy, fuchs' endothelial dystrophy, pseudophakic bullous keratopathy